OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

10368	Companies
215969	Keywords
145712	Articles
114376	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 06/12/2025 at 08:30, 10 months 25 days ago

Oxurion avance dans l'acquisition projetée d'Axiodis
Oxurion NV lève la condition suspensive relative au droit d'information préalable des salariés, avançant vers l'acquisition d'Axiodis CRO. Discussions en cours pour créer des synergies stratégiques. Oxurion se concentre sur la finalisation de l'opération

Acquisition Biopharmaceutique Donnée Clinique Oxurion NV Synergies Stratégiques
PRESS RELEASE

published on 06/12/2025 at 08:30, 10 months 25 days ago

Oxurion moves forward with the planned acquisition of Axiodis
Oxurion NV announces the lifting of a key condition precedent related to the acquisition and focuses on finalizing the transaction and strategic discussions for creating synergies with Axiodis CRO

Acquisition Biopharmaceutical Clinical Data Oxurion NV Strategic Discussions
PRESS RELEASE

published on 06/12/2025 at 08:30, 10 months 25 days ago

Oxurion boekt vooruitgang met de voorgenomen overname van Axiodis
Oxurion NV meldet die Erfüllung der aufschiebenden Bedingung hinsichtlich des Informations- und Konsultationsrechts der Arbeitnehmer für die Übernahme von Axiodis CRO. Oxurion konzentriert sich auf die Fertigstellung der Transaktion und beschleunigt Gespräche mit anderen strategischen Zielen zur Schaffung von Synergien in der Region Toulouse

Übernahme Toulouse Oxurion NV Synergien Axiodis CRO
BRIEF

published on 06/11/2025 at 18:05, 10 months 26 days ago

Oxurion reçoit des notifications de transparence d'Atlas Special Opportunities II LLC

Actions Transparence Biopharmaceutique Atlas Special Opportunities Oxurion
BRIEF

published on 06/11/2025 at 18:05, 10 months 26 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC

Actions Transparency Biopharmaceuticals Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 06/11/2025 at 18:00, 10 months 26 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgevingen met betrekking tot aankoop en verkoop van aandelen. Biofarmaceutisch bedrijf in Leuven, België. Meer informatie op www.oxurion.com

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Aankoop Aandelen Verkoop Aandelen
PRESS RELEASE

published on 06/11/2025 at 18:00, 10 months 26 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding share holdings from Atlas Special Opportunities II, LLC, impacting threshold percentages

Share Holdings Oxurion NV Belgian Transparency Legislation Transparency Notifications Atlas Special Opportunities II, LLC
BRIEF

published on 06/04/2025 at 18:05, 11 months 3 days ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actions Atlas Special Opportunities Notification De Transparence Oxurion Législation Belge
BRIEF

published on 06/04/2025 at 18:05, 11 months 3 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Actions Transparency Notification Atlas Special Opportunities Oxurion Belgian Legislation
PRESS RELEASE

published on 06/04/2025 at 18:00, 11 months 3 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen en blijft onder drempel van 5%. Bedrijf combineert therapeutische innovatie met technologieën in klinisch onderzoek

Transparantiekennisgeving Aandelen Oxurion NV Biofarmaceutisch Innovatie

Accesswire

Published on 05/08/2026 at 01:50, 4 hours 46 minutes ago

Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 5 hours 51 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 6 hours 36 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 7 hours 6 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 7 hours 21 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 23:23, 7 hours 12 minutes ago

H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 7 hours 22 minutes ago

EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 8 hours 31 minutes ago

Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 9 hours 53 minutes ago

RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 11 hours 50 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/07/2026 at 19:15, 11 hours 21 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 11 hours 21 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 11 hours 30 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 11 hours 30 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 11 hours 36 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE